CTRI/2021/02/031318Not yet recruitingNot Applicable
AN OPEN LABEL SINGLE ARM CLINICAL STUDY ON COMBINED THE COMBINED EFFECTIVENESS OF PANCHANIMBAKAMCHURNA VATI AND PATHYADI LEPA IN KITIBA KUSHTA(PSORIASIS)
SDM College of Ayurveda Hassan1 site in 1 country30 target enrollmentStarted: February 22, 2021Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Improvement in the PASI scale and symptoms of Kitibha Kushta
Study Overview
Brief Summary
This study is an open label single arm prospective clinical study to assess the effectiveness of panchanimbakam churna vati and pathyadi lepa in management of kitibha kushta within age group of 18 to 60 for 30 days in 30 patients. The study will be conducted in one center in India. Secondary outcomes will be assessed by Pasi scale after 30 days
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients suffering with Kitibha Kushta <5years of chronicity.
- •Patients of either gender, aged between 18-60 years.
- •Patient willing to participate in the study and ready to sign informed consent form.
Exclusion Criteria
- •Patients with systemic illness such as impaired cardiac, renal and hepatic functions.
- •Metabolic disorders namely diabetes mellitus type 2 and essential hypertension.
- •Pregnant women and lactating women.
Outcomes
Primary Outcomes
Improvement in the PASI scale and symptoms of Kitibha Kushta
Time Frame: outcomes will be assessed at baseline, 15 days and 30 days
Secondary Outcomes
- PASI scale(15 days and 30 days)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 2
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative ResectionCarcinoma, HepatocellularNCT06454578Qilu Hospital of Shandong University30
Unknown
Not Applicable
A Prospective, Open-label, Single-arm Clinical StudyRecurrent Glioblastoma MultiformeNCT04689087Sun Yat-sen University40
Completed
Unknown
A clinical study to evaluate the safety and efficacy of Nimson coconut jasmine oil with Vitamin E in improving hair growthCTRI/2023/06/054302Aryanveda Cosmeceuticals30
Recruiting
Phase 1
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic CancerPancreatic CancerNCT06758544Guangdong Provincial People's Hospital18
Not yet recruiting
Not Applicable
Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic CholangiocarcinomaIntrahepatic CholangiocarcinomaNCT06313554Fudan University63